1. Home
  2. KYN vs TMDX Comparison

KYN vs TMDX Comparison

Compare KYN & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kayne Anderson Energy Infrastructure Fund Inc.

KYN

Kayne Anderson Energy Infrastructure Fund Inc.

HOLD

Current Price

$13.57

Market Cap

2.4B

Sector

Finance

ML Signal

HOLD

TMDX

TransMedics Group Inc.

HOLD

Current Price

$77.38

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYN
TMDX
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KYN
TMDX
Price
$13.57
$77.38
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$148.22
AVG Volume (30 Days)
415.2K
1.1M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
8.99%
N/A
EPS Growth
N/A
382.18
EPS
0.71
0.20
Revenue
N/A
$605,494,000.00
Revenue This Year
N/A
$24.25
Revenue Next Year
N/A
$18.75
P/E Ratio
$19.30
$369.15
Revenue Growth
N/A
37.13
52 Week Low
$11.31
$60.11
52 Week High
$14.70
$156.00

Technical Indicators

Market Signals
Indicator
KYN
TMDX
Relative Strength Index (RSI) 44.55 53.04
Support Level $12.93 $64.90
Resistance Level $14.35 $120.60
Average True Range (ATR) 0.26 4.00
MACD -0.04 1.38
Stochastic Oscillator 39.07 70.20

Price Performance

Historical Comparison
KYN
TMDX

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: